Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-responders and Previously Untreatable Patients Save

Date Added
February 13th, 2018
PRO Number
Pro00074653
Researcher
John Sturdivant
Keywords
Cardiovascular, Heart
Summary

The purpose of the study is to test a new way to pace the left side of the heart without using pacing leads, using the WiSE CRT System. In this study, ultrasound will be used to transfer energy from a new type of pacemaker through your body to a special receiver that is placed inside the left ventricle of your heart. The receiver will use the ultrasound energy to pace the heart without using pacing leads.

Institution
MUSC
Recruitment Contact
Kavin Panneerselvam
843-792-0464
panneeer@musc.edu

Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Save

Date Added
September 26th, 2017
PRO Number
Pro00069122
Researcher
John Sturdivant
Keywords
Cardiovascular
Summary

The purpose of this research study is to evaluate the different ways to program a Cardiac Resynchronization Therapy Defibrillator (CRT-D) through the use of software built into the CRT-D system. A CRT-D does not cure heart failure, but many people who receive a CRT device notice that they feel better. The objective of the device programming required by the SMART CRT study is to provide heart failure therapy which improves heart function.

Institution
MUSC
Recruitment Contact
Deborah Everidge
843-792-2944
adamsde@musc.edu

AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial Save

Date Added
November 22nd, 2016
PRO Number
Pro00060406
Researcher
John Sturdivant
Keywords
Cardiovascular, Heart
Summary

The purpose of the AMPLATZER Amulet Left Atrial Appendage (LAA) Occluder Trial is to find out if the Amulet device is safe and effective when compared to another LAA closure device made by another medical device company named Boston Scientific. The other device, called the WATCHMAN LAA closure device, is approved for use in the United States and many countries in Europe, Australia, and other nations. It is implanted in some patients with non-valvular atrial fibrillation to reduce the risk of stroke. The WATCHMAN device will be used as the Control device in this study.

Institution
MUSC
Recruitment Contact
Deborah Everidge
843-792-2944
adamsde@musc.edu

Change_preferences

-- OR --

Create_login